Association of triglyceride-glucose related indices with mortality among individuals with MASLD combined with prediabetes or diabetes
- PMID: 39893457
- PMCID: PMC11786362
- DOI: 10.1186/s12933-025-02616-9
Association of triglyceride-glucose related indices with mortality among individuals with MASLD combined with prediabetes or diabetes
Abstract
Background: The prognostic significance of triglyceride-glucose (TyG)-related indices in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) combined with prediabetes or diabetes is not yet fully understood. In this study, we explored their predictive value for mortality in this specific population.
Methods: Patients with MASLD were identified from the National Health and Nutrition Examination Survey (NHANES III) database. TyG and its related parameters [TyG-waist circumference (TyG-WC), TyG-waist-to-height ratio (TyG-WHtR), TyG-weight-adjusted waist index (TyG-WWI), and TyG-body mass index (TyG-BMI), ] were calculated. To examine the association between TyG-related indices and mortality risk, Cox regression models were utilized. Furthermore, we employed restricted cubic spline (RCS) analysis to investigate potential dose-response relationships. The predictive ability of the TyG indices for mortality was assessed by analyzing the time-dependent area under the curve (AUC).
Results: In the cohort of patients with prediabetes or diabetes, 46.5% were diagnosed with MASLD. Over a median follow-up of 25.4 years, 1,163 individuals (53.9%) died, with 329 (15.3%) deaths attributed to cardiovascular causes and 78 (3.6%) to diabetes. Multivariate Cox regression models showed that TyG, TyG-BMI, TyG-WHtR, TyG-WWI, and TyG-WC were associated with all-cause and cardiovascular/diabetes-specific mortality. Furthermore, RCS analysis revealed a positive linear relationship between the TyG and TyG-WWI indices and all-cause mortality (p for nonlinear = 0.920; p = 0.525, respectively). In contrast, the TyG-WC, TyG-BMI, and TyG-WHtR indices exhibited a positive nonlinear association with all-cause mortality (p for nonlinear = 0.001; = 0.003; = 0.007, respectively). Time-dependent AUC curves demonstrated that the TyG-WWI index was the most robust predictor of both all-cause and cardiovascular mortality.
Conclusions: Elevated levels of TyG, TyG-BMI, TyG-WHtR, TyG-WWI, and TyG-WC indices were associated with a poorer prognosis in MASLD patients with prediabetes or diabetes, with TyG-WWI being the strongest predictor.
Keywords: Diabetes; MASLD; Mortality; Triglyceride-glucose related indices.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: NHANES was conducted with approval by the National Center for Health Statistics Ethics Review Board, and obtained informed written consent from all the individuals involved in the study. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures




Similar articles
-
Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease.Cardiovasc Diabetol. 2024 Jun 1;23(1):188. doi: 10.1186/s12933-024-02287-y. Cardiovasc Diabetol. 2024. PMID: 38824550 Free PMC article.
-
Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease.Cardiovasc Diabetol. 2024 Jul 4;23(1):232. doi: 10.1186/s12933-024-02343-7. Cardiovasc Diabetol. 2024. PMID: 38965572 Free PMC article.
-
Association between triglyceride-glucose (TyG) related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK Biobank.Cardiovasc Diabetol. 2025 Jan 13;24(1):12. doi: 10.1186/s12933-024-02572-w. Cardiovasc Diabetol. 2025. PMID: 39806394 Free PMC article.
-
Triglyceride glucose-weight-adjusted waist index as a cardiovascular mortality predictor: incremental value beyond the establishment of TyG-related indices.Cardiovasc Diabetol. 2025 Jul 30;24(1):306. doi: 10.1186/s12933-025-02873-8. Cardiovasc Diabetol. 2025. PMID: 40739633 Free PMC article.
-
Triglyceride glucose-waist circumference as a predictor of mortality and subtypes of cardiovascular disease: a systematic review and meta-analysis.Diabetol Metab Syndr. 2025 Feb 15;17(1):59. doi: 10.1186/s13098-025-01616-9. Diabetol Metab Syndr. 2025. PMID: 39955571 Free PMC article. Review.
Cited by
-
Association of gut microbiota dietary index with metabolic dysfunction-associated steatotic liver disease: the mediating roles of inflammation and body mass index.Front Nutr. 2025 May 16;12:1573636. doi: 10.3389/fnut.2025.1573636. eCollection 2025. Front Nutr. 2025. PMID: 40453716 Free PMC article.
-
Sex differences in the association between total energy intake and all-cause mortality among patients with metabolic dysfunction-associated steatotic liver disease.Sci Rep. 2025 May 31;15(1):19176. doi: 10.1038/s41598-025-04121-1. Sci Rep. 2025. PMID: 40450061 Free PMC article.
-
Triglyceride-glucose-waist circumference index: A powerful tool for metabolic dysfunction-associated steatotic liver disease.World J Hepatol. 2025 Jul 27;17(7):107668. doi: 10.4254/wjh.v17.i7.107668. World J Hepatol. 2025. PMID: 40747214 Free PMC article. Review.
-
Association of novel triglyceride-glucose-related indices with incident stroke in early-stage cardiovascular-kidney-metabolic syndrome.Cardiovasc Diabetol. 2025 Jul 24;24(1):301. doi: 10.1186/s12933-025-02854-x. Cardiovasc Diabetol. 2025. PMID: 40707904 Free PMC article.
-
Association and predictive value of the triglyceride glucose-weight adjusted waist index for cardiovascular outcomes in patients with type 2 diabetes.Sci Rep. 2025 Jul 8;15(1):24573. doi: 10.1038/s41598-025-08580-4. Sci Rep. 2025. PMID: 40628839 Free PMC article. Clinical Trial.
References
-
- Eslam M, Sanyal AJ, George J, International Consensus Panel. MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999–e20141. - PubMed
-
- Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021;18(9):599–612. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical